CD4+FOXP3− cells from both unaffected colonic tissue and tumors had a lower demethylation than the CD4+FOXP3+ cells (range 51–100% and 53–74% in the tumor and unaffected tissue, respectively; Fig. 1D). This evidence concerns the gene FOXP3 and neoplasm.